Latest Humira news
Early Use of Higher-Efficacy Therapies Recommended for Moderate-to-Severe Crohn Disease
posted November 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
Adalimumab Efficacious Adjunct to Surgery for Hidradenitis Suppurativa
posted August 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Adalimumab Efficacious Adjunct to Surgery for Hidradenitis Suppurativa
posted August 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Longitudinal TNF Levels Mainly Stable With Adalimumab in RA
posted February 1st
by modernClinician Editorial Team
by modernClinician Editorial Team
For patients with rheumatoid arthritis, longitudinal tumor necrosis factor (TNF) concentrations are mainly stable during adalimumab treatment, although early low TNF is strongly linked to nonresponse to treatment, according to a study published in the Jan. 30 issue of Science Translational Medicine.
Exposure to Air Pollutants Linked to Increased RA Disease Activity
Timing of JAK Initiation, Shingles Vaccine Administration Can Affect Outcomes in RA
Consensus Statements Developed for Rheumatoid Arthritis-Linked Interstitial Lung Disease
Longer Persistence Seen With Upadacitinib Versus TNFi in Rheumatoid Arthritis
California Lawsuit Claims AbbVie Paid Doctors to Prescribe Humira
ABP 501, Adalimumab Biosimilar, Safe and Effective, for Psoriasis
Drug-Induced Lupus Seen With Adalimumab Treatment